Alpha1-Antitrypsin Polymorphism in Fibromyalgia Syndrome Patients from the Asturias Province in Northern Spain: A Significantly Higher Prevalence of the PI*Z Deficiency Allele in Patients Than in the General Population

REFERENCES

• American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Resp Clin Care Med 2003; 168: 818–900
   PubMed Web of Science ®Google Scholar
• Brantly M. α1-Antitrypsin: Not just an anti-protease. Extending the half-live of a natural anti-inflammatory molecule by conjugation with poliethylene glycol. Am J Respir Cell Mol Biol 2002; 27: 652–654
   PubMed Web of Science ®Google Scholar
• Spencer L T, Paone G, Krein P M, Rouhani F N, Rivera-Nieves J, Brantly M L. The role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004; 286(3)514–520
   PubMed Web of Science ®Google Scholar
• Carrell R W, Lomas D A. Alpha1-antitrypsin deficiency-A model for conformational diseases. N Engl J Med 2002; 346(1)45–53
   PubMed Web of Science ®Google Scholar
• de Serres F J. Worldwide racial and ethnic distribution of alpha- 1-antitrypsin deficiency: Details of an analysis of published genetic epidemiological surveys. Chest 2002; 122(5)1818–1829
   PubMed Web of Science ®Google Scholar
• Blanco I, Fernandez E, Bustillo E F. Alpha-1-antitrypsin PI phenotypes S and Z in Europe: An analysis of the published surveys. Clin Genet 2001; 60(1)31–41
   PubMed Web of Science ®Google Scholar
• Blanco I, Bustillo E F, Rodriguez M C. Distribution of a 1-antitrypsin PI S and PI Z frequencies in countries outside Europe: A meta-analysis. Clin Genet 2001; 60(6)431–441
   PubMed Web of Science ®Google Scholar
• Neumann L, Buskila D. Epidemiology of fibro-myalgia. Current Pain and Headache Rep 2003; 7(5)362–368
   PubMedGoogle Scholar
• Nampiaparampil D E, Shmerling R H. A review of fibromyalgia. Am J Manag Care 2004; 11: 794–800
   Google Scholar
• Carmona L, Ballina J, Gabriel R, Laffton A. EPISER study group. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Ann Rheum Dis 2001; 60(11)1040–1045
   PubMed Web of Science ®Google Scholar
• Rao S G, Clauw D J. The management of fibromyalgia. Drugs of Today 2004; 40(6)539–554
   PubMed Web of Science ®Google Scholar
• Wallace D J, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman M H. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumathology [Oxford] 2001; 40(7)743–749
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L, Press J. Genetic factors inneuromusclarpain. CNS Spectr 2005; 10(4)281–284
   PubMed Web of Science ®Google Scholar
• Blanco I, Canto H, de Serres F J, Bustillo E F, Rodriguez M C. Alpha-1-antitrypsin replacement therapy efficiently controls fibromyalgia symptoms in two PI ZZ alpha- 1-antitrypsin deficiency patients. J Rheumatol 2004; 31(10)2082–2085
   PubMed Web of Science ®Google Scholar
• Blanco I, de Serres F J, Fernandez-Bustillo E, et al. Alpha 1-antitrypsin and fibromyalgia: New data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses 2005; 64(4)759–69
   PubMed Web of Science ®Google Scholar
• Blanco I, Fernandez E, Rodriguez M C, Fernandez A. Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias. Med Clin [Bare] 1999; 113(10)366–370
   PubMed Web of Science ®Google Scholar
• Blanco I, Fernandez E. al-antitrypsin Pi phenotypes S and Z in Spain: An analysis of the published surveys. Respir Medicine 2001; 95: 109–114
   PubMed Web of Science ®Google Scholar
• de Serres F J, Blanco I, Bustillo E F. Genetic epidemiology of alpha-1 antitrypsin deficiency in Southern Europe: France, Italy, Portugal, and Spain. Clin Genet 2003; 63: 1818–1829
   Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Nita I, Hollander C, Westin U, Janciauskiene S. Prolastin, a pharmaceutical preparation of purified human alphal-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res 2005; 31(1)12–18
   Google Scholar
• Stockley R A. Alpha-1 antitrypsin: More than just deficiency. Thorax 2004; 59(5)363–364
   PubMed Web of Science ®Google Scholar
• Carrel R W, Lomas D A, Sidhar S, Foreman R. a-Antitrypsin, a conformational disease. Chest 1996; 110: 243S–247S
   PubMed Web of Science ®Google Scholar
• Aldonyte R, Janson L, Ljungberg O, Larsson S, Janciauskiene S. Polymerized alpha-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of alpha-antitrypsin polymerization. Histopathology 2004; 45(6)587–592
   PubMed Web of Science ®Google Scholar
• Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley D G, Parmar J, Pitman R, Shapiro S D, Lomas D A. Polymers of Z alphal-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005; 166(2)377–386
   PubMed Web of Science ®Google Scholar